Post-transcriptional regulation in cancer chemoresistance
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2026-09 · 1881 (4) · 189650
DOI: 10.1016/j.bbcan.2026.189650 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2026-09. Verfasst von Sabrina De Lella und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Neoplasms, Gene Expression Regulation, Neoplastic, RNA Processing, Post-Transcriptional. Die Arbeit nennt 182 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'Istruzione dell'Universita e della Ricerca, Airc Italian Foundation for Cancer Research.
Abstract (Originalsprache)
Cancer remains the second leading cause of death worldwide, surpassed only by cardiovascular diseases. Although cancer-specific mortality rates have declined due to advances in early detection and therapeutic strategies, the absolute number of cancer-related deaths continues to rise, driven by increasing disease incidence associated with population aging and lifestyle factors. A substantial proportion of cancer mortality is attributable to the development of resistance to anticancer therapies, making drug resistance a critical barrier to durable treatment efficacy and a major focus for clinical and translational research. Drug resistance arises from a wide spectrum of molecular and microenvironmental adaptations that enable cancer cells to limit drug uptake, neutralize or bypass drug activity, and evade therapy-induced cell death. These adaptive processes are orchestrated by extensive rewiring of gene expression programs, regulatory networks, and signaling pathways, ultimately reshaping cellular metabolism and stress responses. Traditionally, such adaptations have been primarily ascribed to genetic alterations and transcriptional reprogramming. However, growing evidence indicates that posttranscriptional regulatory mechanisms play a pivotal and previously underappreciated role in modulating gene expression and protein activity during the acquisition of drug-resistant phenotypes. RNA-mediated mechanisms, including regulation of mRNA stability, translation, subcellular localization, and RNA-protein interactions, introduce a dynamic and reversible level of control over protein expression and activity. In particular, non-canonical RNA-binding proteins, diverse classes of non-coding RNAs, and riboregulatory mechanisms have emerged as critical modulators of pathways involved in drug transport, DNA damage response, apoptosis, and metabolic adaptation. These processes allow cancer cells to rapidly fine-tune functional proteomes without requiring permanent genetic changes, thereby facilitating phenotypic plasticity and therapeutic escape. In this review, we summarize recent advances in the field, with a particular emphasis on emerging posttranscriptional mechanisms of gene regulation that contribute to anticancer drug resistance. By highlighting the dynamic and multilayered nature of RNA-mediated regulatory processes, we aim to provide a comprehensive framework for understanding how cancer cells adapt to therapeutic pressure and to identify novel avenues for therapeutic intervention in the context of drug-resistant disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.
- Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy. Electronic address: daniloswann.matassa@unina.it.
- Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy. Electronic address: rosario.avolio@unina.it.
Förderung
- Ministero dell'Istruzione dell'Universita e della Ricerca
- Airc Italian Foundation for Cancer Research
Zitieren
APA
De Lella, S., Esposito, F., Matassa, D. S., & Avolio, R. (2026). Post-transcriptional regulation in cancer chemoresistance. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1881(4), 189650. https://doi.org/10.1016/j.bbcan.2026.189650
Vancouver
De Lella S, Esposito F, Matassa DS, Avolio R. Post-transcriptional regulation in cancer chemoresistance. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2026;1881(4):189650. doi:10.1016/j.bbcan.2026.189650
BibTeX
@article{DeLella2026,
author = {De Lella, Sabrina and Esposito, Franca and Matassa, Danilo Swann and Avolio, Rosario},
title = {Post-transcriptional regulation in cancer chemoresistance},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2026},
volume = {1881},
number = {4},
pages = {189650},
doi = {10.1016/j.bbcan.2026.189650}
}
EUVIMED